Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension-Reference-Cited by-同舟云学术

Antihypertensive and metabolic effects of empagliflozin in Ren-2 transgenic rats, an experimental non-diabetic model of hypertension

Published:2021-12 Issue: Volume:144 Page:112246
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Hojná Silvie,Rauchová Hana,Malínská Hana,Marková Irena,Hüttl Martina,Papoušek František,Behuliak Michal,Miklánková Denisa,Vaňourková Zdeňka,Neckář Jan,Kadlecová Michaela,Kujal Petr,Zicha Josef,Vaněčková Ivana

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference58 articles.

1. EMPA-REG OUTCOME Investigators, Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N. Engl. J. Med.,2015

2. CANVAS Program Collaborative Group, Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N. Engl. J. Med.,2017

3. Evaluating the effects of canagliflozin on cardiovascular and renal events in patients with type 2 diabetes mellitus and chronic kidney disease according to baseline HbA1c, including those with HbA1c <7%: results from the CREDENCE trial;Cannon;Circulation,2020

4. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics;Wheeler;Nephrol. Dial. Transplant.,2020

5. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials;Zannad;Lancet,2020

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gliflozins in the Treatment of Non-diabetic Experimental Cardiovascular Diseases;Physiological Research;2024-08-31

2. Empagliflozin alters lipid metabolism in the myocardium and liver in a prediabetes model with severe dyslipidemia;Frontiers in Pharmacology;2024-07-04

3. Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet;Biomedicine & Pharmacotherapy;2024-05

4. Empagliflozin attenuates radiation-induced hematopoietic damage via NOX-4/ROS/p38 pathway;Life Sciences;2024-03

5. Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-κB-dependent cardiomyocyte pyroptosis;Biomedicine & Pharmacotherapy;2024-01